Reply to ‘Depression and clinical outcomes in CKD: do anti-depressants play a role? (EQUAL Study)’
暂无分享,去创建一个
F. Dekker | C. Wanner | M. Evans | F. Caskey | K. Jager | M. Krajewska | Robbert W. Schouten | Willem-Jan W. Bos | N. Chesnaye | W. Michels | O. Heimburger | Y. Meuleman | M. Szymczak | B. C. E. Maarse | M. Evans
[1] M. Brookhart,et al. Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis. , 2019, Journal of the American Society of Nephrology : JASN.
[2] Jolene R. Bostwick,et al. A Comparison of the Risk of QT Prolongation Among SSRIs , 2013, The Annals of pharmacotherapy.
[3] G. Andersson,et al. A Meta-Analysis of Cognitive-Behavioural Therapy for Adult Depression, Alone and in Comparison with other Treatments , 2013, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[4] Raymond Vanholder,et al. Antidepressants for depression in stage 3-5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP). , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[5] A. Honig,et al. Validity of the Hospital Anxiety and Depression Scale and the Beck Depression Inventory for use in end-stage renal disease patients. , 2010, The British journal of clinical psychology.
[6] A. Mackinnon,et al. Validity of the mental health component scale of the 12-item Short-Form Health Survey (MCS-12) as measure of common mental disorders in the general population , 2007, Psychiatry Research.
[7] Bruce Friedman,et al. Validity of the SF‐36 Five‐Item Mental Health Index for Major Depression in Functionally Impaired, Community‐Dwelling Elderly Patients , 2005, Journal of the American Geriatrics Society.
[8] J. Ware. SF-36 health survey: Manual and interpretation guide , 2003 .